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Abstract
Background: When resources are scant, C. elegans larvae arrest as long-lived dauers under the
control of insulin/IGF- and TGFβ-related signaling pathways. However, critical questions remain
regarding the regulation of this developmental event. How do three dozen insulin-like proteins
regulate one tyrosine kinase receptor to control complex events in dauer, metabolism and aging?
How are signals from the TGFβ and insulin/IGF pathways integrated? What gene expression
programs do these pathways regulate, and how do they control complex downstream events?
Results: We have identified genes that show different levels of expression in a comparison of wild-
type L2 or L3 larvae (non-dauer) to TGFβ mutants at similar developmental stages undergoing
dauer formation. Many insulin/IGF pathway and other known dauer regulatory genes have changes
in expression that suggest strong positive feedback by the TGFβ pathway. In addition, many insulin-
like ligand and novel genes with similarity to the extracellular domain of insulin/IGF receptors have
altered expression. We have identified a large group of regulated genes with putative binding sites
for the FOXO transcription factor, DAF-16. Genes with DAF-16 sites upstream of the
transcription start site tend to be upregulated, whereas genes with DAF-16 sites downstream of
the coding region tend to be downregulated. Finally, we also see strong regulation of many novel
hedgehog- and patched-related genes, hormone biosynthetic genes, cell cycle genes, and other
regulatory genes.
Conclusions: The feedback regulation of insulin/IGF pathway and other dauer genes that we
observe would be predicted to amplify signals from the TGFβ pathway; this amplification may serve
to ensure a decisive choice between "dauer" and "non-dauer", even if environmental cues are
ambiguous. Up and down regulation of insulin-like ligands and novel genes with similarity to the
extracellular domain of insulin/IGF receptors suggests opposing roles for several members of these
large gene families. Unlike in adults, most genes with putative DAF-16 binding sites are upregulated
during dauer entry, suggesting that DAF-16 has different activity in dauer versus adult metabolism
and aging. However, our observation that the position of putative DAF-16 binding sites is
correlated with the direction of regulation suggests a novel method of achieving gene-specific
regulation from a single pathway. We see evidence of TGFβ-mediated regulation of several other
classes of regulatory genes, and we discuss possible functions of these genes in dauer formation.
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Background
Changes in environmental conditions alter the physiol-
ogy of all organisms. Evolution and experience create a
signaling architecture that assesses current conditions and
makes changes in physiology to attain the most appropri-
ate state for a predicted future condition. The dauer larva
of C. elegans forms when sensory inputs suggest that food
resources will be inadequate for successful reproduction
[1]. Food availability, competition for available food
resources (population density, as measured by the con-
centration of a constitutively secreted pheromone), and
temperature are assessed by identified chemosensory and
thermosensory neurons, and signals are transduced from
these neurons to affect the physiology and structure of
most cell types in the body. Development is arrested after
the second larval molt, and the third-stage larva that is
formed is structurally and behaviorally specialized for dis-
persal and long-term survival.
Figure 1 shows two pathways, related to TGFβ and insu-
lin/IGF pathways in vertebrates, which repress dauer for-
mation under non-inducing conditions [1-4]. Studies of
these signaling pathways have led to some understanding
of the basic role of these pathways in regulating dauer for-
mation. Environmental cues received by chemosensory
neurons regulate the transcription of genes that encode
ligands in each of these pathways:daf-7 in the TGFβ path-
way and daf-28 and perhaps other insulin-like ligands in
the insulin/IGF pathway [5-7]. daf-7  and  daf-28  are
expressed in chemosensory neurons in the amphid sensil-
lae, which senses environmental cues that regulate dauer
formation. Experiments in which components of the
TGFβ and insulin/IGF pathways were expressed from tis-
sue-specific promoters suggest that these pathways func-
tion predominantly or entirely in the nervous system to
control dauer formation [8-10]. Little is known about
how transcription factors regulated by these pathways
control dauer entry, except that these signaling pathways
probably influence a hormonal signal, because most of
the cells altered in dauer are not innervated. Two compo-
nents downstream of these pathways are DAF-12, a
nuclear hormone receptor [11], and DAF-9, a cytochrome
p450 that is a putative hormone biosynthetic enzyme
[12,13]; these two genes suggest that the secondary signal
may be a ligand derived from a lipid.
Signal transduction pathways that regulate dauer Figure 1
Signal transduction pathways that regulate dauer. Relationships between genes are based on mutant phenotypes and 
genetic interactions, gene expression in mutants, and homology to pathways in other organisms.
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Dauers are long-lived [1], and mutations in many genes,
particularly insulin/IGF pathway genes, affect C. elegans
lifespan [14]. The role of the insulin/IGF pathway in aging
appears to be shared by related pathways in Drosophila
and mice [15]. Unlike mutations in insulin/IGF pathway
genes, mutations in TGFβ pathway genes do not extend
adult lifespan.
Many genes have been shown to be regulated by dauer
formation and by the insulin/IGF pathway. However, no
previous studies have focused on regulation of the deci-
sion to enter dauer. In the present study, we have used
microarray-based analysis of gene regulation in C. elegans
TGFβ mutants to identify genes that are directly and indi-
rectly regulated by TGFβ signaling during the dauer for-
mation process. Using a stringent definition for
significance, we identified over 1200 genes that are upreg-
ulated and downregulated in dauer entry. In this study, we
focus on the expression and regulation of genes that
encode proteins involved in signal transduction and gene
regulation. Analysis of these genes has helped suggest
mechanisms by which TGFβ signaling might regulate a
secondary hormonal cue and how signaling from TGFβ,
insulin/IGF, and other dauer regulators is integrated.
We have identified genes that show different levels of
expression in a comparison between wild type L2 or L3
larvae (non dauer), and several TGFβ mutants undergoing
dauer larva formation (L2d-early dauer). We identify a
large number of genes encoding regulatory proteins that
are regulated by TGFβ signaling; of special interest are a
large group of putative hormone biosynthetic enzymes
and hormone receptors. We see strong regulation of many
genes related to Hedgehog and its receptor, Patched; our
analysis of genes coregulated with these signaling mole-
cules suggests that the dauer-regulated members of this
family function in cuticle synthesis or other hypodermal
functions. Genetic evidence shows that inactivation of
either the TGFβ pathway or the insulin/IGF pathway is
sufficient to induce dauer formation. These results can be
explained in on of two ways. First, inactivation of either
pathway, even with continued activity of the parallel path-
way, causes dauer formation. Second, inactivation of one
pathway may lead to an inactivation of the other. We
show that, when the TGFβ pathway is inactive, expression
of several genes is regulated in such a way as to decrease
signaling in the insulin/IGF pathway. Also, expression of
the  daf-12  nuclear hormone receptor gene is strongly
upregulated and expression of the daf-9 cytochrome p450
gene is downregulated. These results suggest that feedback
inactivation of the insulin/IGF pathway and feedback reg-
ulation of other genes may be required in order for TGFβ
pathway mutants to cause dauer formation. We suggest
that this feedback promotes a clear on/off decision for
dauer, even under moderate dauer-inducing conditions,
and discuss the relevance of feedback for control of aging.
We find altered expression of more than 70 genes with
putative DAF-16 regulatory sites, and find that whether
these genes are upregulated or downregulated depends on
the location of the putative DAF-16 site. Finally, we see
regulation of many insulin-related genes as well as genes
that encode proteins similar to the extracellular domain of
insulin/IGF receptors; this variety of signaling molecules
may allow insulin/IGF signaling to have a dramatically
different outcome in dauers and adults.
Results
Array-based hybridization experiments and analysis of 
expression profiles
We compared gene expression in C. elegans wild type to
that of animals mutant for the TGFβ pathway genes daf-7
(ligand; [5,6]), daf-8 and daf-14 (Smad transcription fac-
tors; [8,16]). At 25°, these daf-c  mutants form an L2d
instead of the L2 larva, and begin dauer morphogenesis
after the L2d to dauer molt. Completion of morphogene-
sis takes about 12 hours from the molt [1]. For all experi-
ments, we examined RNA from animals close to the molt
between the L2 (or L2d) and L3 (or dauer). We compared
wild-type animals that had just completed the lethargus
associated with the L2/L3 molt to daf-7 animals that had
just completed the lethargus associated with the L2d/
dauer molt (four independent experiments). For compar-
isons of daf-8 or daf-14 to wild type, we used a slightly ear-
lier stage, and compared wild type animals near the
beginning of the L2/L3 lethargus to animals near the
beginning of the L2d/dauer lethargus (three independent
experiments each).
We found that many genes showed significant regulation
in at least one genotype (t-test p < 0.05; Table 1; full data
in additional file 1: Table S1). More than 90% of the genes
showed consistent regulation; if a gene had significantly
altered expression in one mutANT, the gene was regulated
in the same direction in the other two mutants (Fig. 2).
This consistency is not surprising, because all three daf-c
genes are in the same signal transduction pathway and
have similar phenotypes. Because the results from the
three daf-c genotypes were broadly similar, we analyzed
combined data from all three genotypes. By repeating our
statistical analysis on the combined data set, we identified
3248 (out of genes that were significantly up- or down-
regulated (P < 0.01). We identified over 1200 genes that
were strongly regulated (>2.1 fold, p < 0.01; see additional
file 2: Table S2).
We compared our results to published analysis of gene
expression in dauers. Many studies have reported the
identification of "dauer-regulated" genes, but this term
covers a vast range of very different experiments, and we
carefully selected data for validation (see Methods). WeBMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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found that our data was in good agreement with pub-
lished data from experiments of similar design (see
Methods and Table 2); 7 of 8 genes examined were simi-
larly regulated in our data and published experiments.
Many strongly regulated early dauer genes have DAF-16 
regulatory sites
We examined the regulated genes in our data set to see if
we could identify possible cis-acting regulatory sites.
Three Smads (DAF-8, DAF-14, and DAF-3) act down-
stream of the receptors. Two of the Smads do not have an
Table 1: Significantly regulated early dauer genes in three TGFβ pathway mutants.
Genotype Harvest stage Number of experiments # genes up-regulated p < 0.05a # genes down-regulated p < 0.05
daf-7 vs. wild type early dauer/L3 4 351 1069
daf-8 vs. wild type late L2d/L2 3 180 679
daf-14 vs. wild type late L2d/L2 3 552 1276
daf-c vs. wild typeb 10 2540 3076
a Upregulated genes are expressed at a higher level in daf-c mutants than in wild type, and downregulated are the reverse.
b This row is not a summary of the rows above, rather, it is a reanalysis of the data with all ten experiments considered together.
Cluster diagram of gene expression responses Figure 2
Cluster diagram of gene expression responses. Each row represents an average of 3–4 independent experiments. Each 
gene on the array is represented as a line in each column. The color of the line represents the log2 of the expression ratio, as 
indicated by the scale bar.
Table 2: Comparison of microarray data to published experiments.
Gene Method Published difference Fold change, this study P value
C27H5.5/col-36 RT-PCR L2d/dauer >> L2/L3a [64] 6.8 <0.008
C47G2.1/cut-1 Northern L2d/dauer >> L2/L3a [65] 5.7 <0.003
C08A9.1/sod-3 Northern present in dauer, absent in non-dauer [66] 7.8 <0.00001
T01B7.7/rol-6 Northern and slotblot L2/L3 >> L2d/dauera [61] -7.4 <0.00002
B0491.2/sqt-1 Northern and slotblot L2/L3 >> L2d/dauera [61] -7.0 <0.0002
T23G5.1/rnr-1 GFP fusion not seen at L2d/dauer molt, seen in cells in 
S phase at L2/L3 molt [67]
-1.8 <0.05a
W01B6.7/col-2 Northern and slotblot L2d/dauer >> L2/L3a [61] 2.2 <0.02
T13B5.4/col-40 RT-PCR L2d/dauer >> L2/L3a [64] 1.1 <0.8
a L2d/dauer refers to animals near the molt between these two larval stages; L2/L3 also refers to animals near the molt.
b The P value for rnr-1 was calculated using only the local standard deviation because the global standard deviation was not available.BMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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identifiable DNA binding domain [4,5,16], and may serve
to negatively regulate the DAF-3 Smad [4,17]. Unfortu-
nately, the optimal binding site for DAF-3 is only 5 bp
[18]. Most genes (>80%) have a DAF-3 binding site within
2000 bp upstream of the ATG (data not shown).
Therefore, we focused on the insulin/IGF pathway that
regulates DAF-16, which has an eight bp optimal binding
site in experiments performed in vitro, TTGTTTAC [19].
We expect that regulated genes in our data set include tar-
gets of DAF-16 for three reasons. First, signaling from the
insulin/IGF pathway is decreased in the TGFβ pathway
mutants (see below). DAF-16 is negatively regulated by
DAF-2 signaling, so we would expect that DAF-16 would
be more active in our mutant worms. Second, DAF-16
relocalizes to the nucleus when it is active, and daf-7
mutants accumulate DAF-16 in the nucleus during dauer
entry [20]. Third, DAF-16 and DAF-3 both promote dauer
formation, so might have targets in common.
We see strong evidence that genes with DAF-16 sites
upstream of transcription are likely to be upregulated.
2.7% of genes without DAF-16 sites are strongly upregu-
lated, but genes with DAF-16 sites in all intervals from -1
to -1500 have significantly more upregulated genes (Fig.
3A, additional file 3: Table S3). 82 genes with a DAF-16
site within 1500 bp upstream of the translation start are
strongly upregulated against a random expectation of 40.
We also examined genes that did not meet our most strin-
gent criteria for regulation: these genes were at least two-
fold upregulated, but not included in the analysis in Fig.
3A. We found 50 genes with a DAF-16 binding site within
700 bp upstream of the translation start against a random
expectation of 24 (Fig. 3B; additional file 3: Table S3). We
examined 734 strongly downregulated genes, and see no
increased likelihood of upstream DAF-16 sites (58 genes
expected, 58 observed). When we examined genes with
DAF-16 sites within 200 bp downstream of the stop
codon, we see no correlation with upregulation (Fig. 3C).
However, we see 15 downregulated genes with DAF-16
binding sites against a random expectation of 6 (Fig. 3D,
additional file 3: Table S3).
Insulin/IGF pathway signaling is regulated by feedback 
from TGFβ signaling
Insulin/IGF receptor kinase and other downstream signaling 
molecules
Because we found significant regulation of genes with
DAF-16 binding sites, we examined regulation of genes in
the insulin/IGF pathway, which acts to antagonize DAF-
16 signaling. Several genes in the insulin/IGF-like path-
way that regulates dauer formation (see Fig. 1) are
strongly regulated. The most critical of these is daf-2,
which encodes the insulin/IGF receptor, because, down-
stream of the receptor, the pathway bifurcates, and
mutants in downstream genes have weaker phenotypes
[21-23]. Downregulation of daf-2  in TGFβ pathway
mutants suggests that signaling from the TGFβ pathway
positively regulates signaling from the insulin/IGF path-
way. Published genetic analysis shows that a nuclear hor-
mone receptor, DAF-12, is antagonized by signaling from
the TGFβ receptors [3]. One means of antagonism may be
to regulate a hormone that controls DAF-12 activity. A
cytochrome p450 gene, daf-9, has a partial dauer constitu-
tive mutant phenotype, and acts upstream of daf-12 and
downstream of the TGFβ pathway to repress dauer forma-
tion [12,13]. In dauers, a daf-9::GFP reporter is downreg-
ulated in hypodermis and upregulated in a pair of cells in
the head [12]. We see strong downregulation of daf-9 in
our data; these results are consistent, given that the hypo-
dermis is at least two orders of magnitude larger than the
head cells. We also find that daf-12 itself is strongly upreg-
ulated in our data; this is a form of regulation that had
been previously unidentified. Upregulation of daf-12 and
downregulation of daf-2 and daf-9 would all be predicted
to induce dauer formation.
Other genes in the insulin/IGF pathway are regulated, but
the regulation is complex, with both induction and
repression. AKT-1, ATK-2 and PDK-1 are kinases that neg-
atively regulate DAF-16, a FOXO transcription factor. A
loss of function mutation in pdk-1 causes a dauer consti-
tutive phenotype that is much weaker than null mutations
in daf-2 [23]. Simultaneous knockdown of akt-1 and akt-2
by RNAi also gives a dauer constitutive phenotype that
also is weaker than a daf-2 null. Single knockdown of akt-
1 or akt-2 by RNAi does not produce a dauer constitutive
phenotype [24]. The weaker phenotype of akt-1, akt-2 and
pdk-1 is at least partly due to redundancy in the pathway;
a second output from DAF-2 is transduced by IST-1 [21].
The phenotypes may also be weaker because the genes
were not completely knocked out by RNAi. We see upreg-
ulation of pdk-1 and one isoform of akt-1, and downregu-
lation of akt-2, one isoform of akt-1, and some, but not all,
isoforms of daf-16. The overall effect of this mix of regula-
tion is hard to predict, but suggests variable function for
different genes and isoforms. For example, akt-1a, akt-1b
and akt-2 may be differently regulated in different tissues,
with the result that the output of signal transduction is
subtly different.
Regulation of insulin/IGF and novel genes with similarity to the 
extracellular domain of insulin/IGF
C. elegans has one insulin/IGF receptor kinase, but dozens
of insulin-related genes [24]. The reason for the abun-
dance of ligands is unclear, but perhaps multiple insulin-
like ligandss allow for different temporal and spatial pat-
terns of receptor activation, or produce receptor-ligand
complexes with different activities. The structure of the
insulin-like genes is quite diverse, with three major groupsBMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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Regulation of genes with DAF-16 binding sites Figure 3
Regulation of genes with DAF-16 binding sites. In all panels, the bars show groups defined by the location of DAF-16 
sites, as shown on the X-axis. We used overlapping intervals to allow robust statistical analysis. Negative numbers are bp 
upstream of the initiation codon, and positive numbers are bp downstream of the stop codon. Asterisks indicate statistical sig-
nificance (exact hypergeometric probability) of the proportion of strongly regulated genes in the group compared to all 
genes:*** is p < 0.001, ** is p < 0.01, * is p < 0.05. A. Strongly upregulated (>2.1 fold, p < 0.01) genes. B. Two fold upregulated 
genes, excluding those genes in panel A. C. Strongly upregulated genes with downstream DAF-16 sites. D. Strongly downregu-
lated (<2.1 fold, p < 0.01) genes.BMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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defined by the pattern of disulfide bonds, and subgroups
defined by differences in gene structure [24]. Diversity in
function of insulin like genes has been demonstrated;
INS-4, INS-6, INS-7 and DAF-28 have been shown by
genetic or biochemical analysis to be receptor agonists
[7,25,26], and INS-1 and INS-18 act as antagonists [24].
We see strong upregulation and downregulation of a sub-
set of these insulin-like genes. Insulin-like genes in C. ele-
gans have been divided into three types on the basis of
disulphide bonding patterns [24]. These three groups can
be further subdivided on the basis of other sequence fea-
tures. One subgroup has 9 genes, ins-2 through ins-9, and
daf-28. Six of these are present on the array, and four (ins-
4, ins-5, ins-6 and ins-7) show significant downregulation
(Table 3). The other two insulin-like genes in this family
that are present on the array (ins-2 and ins-3) are not sig-
nificantly changed. INS-6 has been shown to be a receptor
agonist in vitro [25]. Overexpression of ins-4 and ins-6 can
partially or completely rescue a daf-28 mutant [7], and ins-
7 RNAi enhances a weak daf-2 mutant [26], suggesting
that these insulin-like ligands act as DAF-2 agonists. Three
insulin-like genes are upregulated (Table 3); only one of
the three, ins-18, has an identified function, and it acts as
a receptor antagonist [24]. Increased expression of this lig-
and, like reduction in expression of daf-2,  ins-6, etc.,
would be expected to promote dauer formation.
Table 3: Dauer and aging genes regulated by TGFβ signaling.
Gene Induces or represses dauer?a Fold regulationb p value
insulin pathway
daf-2 (receptor) strongly represses -3.1 <0.0001
akt-2 represses -3.0 <0.0001
akt-1 allc represses 1.0 ns
akt-1ac unknown -1.8 <0.003
akt-1bc unknown 1.4 <0.03
pdk-1 represses 1.8 <0.0001
daf-16ad unknown 1.0 ns
daf-16 alld promotes -1.7 <0.0004
Insulin-like ligands
ins-4 repressese -2.1 <0.002
ins-5 unknown -2.6 <0.02
ins-6 repressese -2.6 <0.02
ins-7 represses -2.1 <0.005
ins-18 promotese 1.8 <0.002
ins-33 unknown 3.9 <0.0003
ins-35 unknown 6.5 <0.0001
insulin receptor-like
F56A4.C unknown -3.5 <0.0001
Y19D10A.7 unknown -2.8 <0.0003
F14D2.6 unknown 1.8 <0.006
F15E11.11 unknown 1.8 <0.008
other dauer and aging regulators
daf-12 strongly induces 2.2 <0.0007
daf-5 induces -2.0 <0.0003
daf-9 represses -4.2 <0.02
scl-1 unknown 5.2 <0.006
ns, not significant This
table shows all insulin-like ligands, insulin-receptor-like genes, TGFβ, and insulin/IGF pathway genes with greater than 1.8-fold regulation and a p 
value less than 0.05. Genes checked for regulation that showed <1.8 fold regulation or p > 0.05 or both: clk-1, clk-2, sir-2.1, daf-11, daf-7, daf-1, daf-
4, daf-14, daf-8, daf-3, daf-19, tax-4, npc-1, daf-18, age-1, old-1, mev-1, hsf-1, daf-21, gpa-2, gpa-3, kin-29, kin-8, unc-3 and tph-1, as well as all genes 
annotated as insulins present on the microarray (ins-2, ins-3, ins-11, ins-17, ins-22, ins-23, ins-24, ins-26, ins-30, ins-32, ins-34, ins-37) and nearly all 
genes identified as putative insulin receptors in Dlakic [27].
aInduction or repression of dauer is defined by mutant or RNAi loss-of-function phenotypes unless otherwise noted. daf-9 mutants have 
characteristics similar to both types, and are thus marked "mixed".
cThe fold change between mutant dauers and wild-type. A positive number indicates higher expression in dauers, a negative number indicates higher 
expression in N2.
cThe table entry "akt-1 all" is for a probe that recognizes both isoforms. The other two akt-1 entries each cover an exon unique to the indicated 
isoform.
dThe entry "daf-16a isoform" is for a probe that recognizes:R13H8.1c (daf-16a1), R13H8.1b (daf-16a2), and R13H8.1d, but not R13H8.1a (daf-16b) 
or R13H8.1e. The entry "daf-16 all" is for a probe that recognizes all five isoforms of daf-16.
eOverexpression of ins-4 or ins-6 represses dauer in a daf-28 mutant [7]. ins-6 has also been shown biochemically to act as a receptor agonist [25]. 
Overexpression of ins-18 promotes dauer [24].BMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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A family of genes with modest but significant similarity to
the ligand binding domain of insulin/IGF receptor has
been identified [27], and these may contribute to insulin/
IGF signaling and signaling diversity; however, because of
weak similarity to insulin/IGF receptor and similarity to
other receptor tyrosine kinase ligand binding domains, a
function in insulin/IGF signaling is speculative. As with
the insulin-like genes, we see both upregulation and
downregulation of insulin-receptor like molecules.
Regulation of regulatory genes
Genetic and molecular analysis has allowed us to gain a
basic understanding of the key regulatory pathways that
affect dauer formation by acting in the nervous system,
but we know little about regulatory events downstream of
these pathways, i.e. the regulators that actually control
dauer morphogenesis and physiology. Below, we discuss
a selected set of regulated genes; a complete list of regula-
tory genes can be found in additional file 4: Table S4.
Regulators of aging
Because dauers are long lived, and because many genes
that control lifespan also control dauer entry, we exam-
ined the expression of genes with mutant phenotypes of
long or short lifespan. Other than the insulin/IGF path-
way genes mentioned above, scl-1 was the only aging reg-
ulatory gene we identified as strongly regulated (Table 3).
SCL-1 has an SCP domain, which defines a family of puta-
tive signaling molecules with unknown biochemical func-
tion [28,29]. The scl-1 gene is required for extension of
lifespan in a daf-2 mutant, and scl-1 expression is upregu-
lated in long-lived genotypes [28]. scl-1 is strongly upreg-
ulated in our data as well, and we suggest scl-1 is part of
the mechanism of lifespan extension in dauers. Several
other genes in the scl-1 family are upregulated in old ani-
mals and in mature dauers, but not in our data [29,30,52].
Cytochrome p450s
Cytochrome p450s are versatile enzymes that oxygenate a
wide variety of compounds [31]. These reactions are
involved in protection from toxins, hormone biosynthesis
and other functions. Cytochrome p450s are very promi-
nent among our regulated genes (additional file 4: Table
S4); 43 of 75 are regulated >1.8 fold (p < 0.05). One puta-
tive hormone biosynthetic cytochrome p450, daf-9, is
known to function in dauer formation, and these others
may also participate in hormone metabolism in dauer.
Hedgehog/Patched
In Drosophila and vertebrates, Patched and Smoothened
form a receptor complex that binds Hedgehog ligands. C.
elegans has two functional Patched orthologs and a family
of proteins similar to Patched, called Patched-related.
One, ptc-1, has an RNAi phenotype of defective cytokine-
sis in the germ line [32]. However, none of the patched/
hedgehog family genes shown in Table 4 has an RNAi phe-
notype similar to ptc-1 [51,33]. A group of 10 C. elegans
proteins have a carboxyl terminus that is related to the car-
boxyl terminus of Hedgehog; however, no protein with
substantial similarity to the N-terminal signaling domain
of Hedgehog has been found in C. elegans. Instead the C.
elegans proteins have two novel families of N terminal
sequences, called Wart and Ground domains [34]. Genes
that encode both the N-terminal domain and the Hedge-
hog-related C terminal domain are called warthog  and
groundhog. Some proteins have only Wart or Ground
domains. Finally, a large family of proteins has a domain
that is similar to the Ground domain, and these are called
Ground-like. Careful examination of the sequence indi-
cates that Wart, Ground, and Ground-like domains and
the N terminal domain of Hedgehog, despite low
sequence identity, share motifs that indicate descent from
a common ancestor [34].
We see abundant regulation of these gene families in our
data (Table 4). Both upregulated and downregulated
genes are observed, but downregulated genes are much
more abundant.
Olfaction and other G-protein-coupled receptor signaling
Two of the three well-characterized cues for dauer entry
are food and pheromone, which are sensed by chemosen-
sory neurons. Chemosensation in C. elegans is mediated
by G protein coupled receptors (GPCRs), which regulate
cyclic GMP levels [35]. We see many upregulated G pro-
tein coupled receptors, accessory proteins, and other pro-
teins related to olfaction, but few downregulated genes of
these types (Table 4).
Cell cycle and growth arrest
Many cell types undergo cell cycle arrest in dauers. We see
downregulation of cdk-4 (homologous to human Cdk-4/
Cdk-6), which is well suited to control cell cycle arrest in
dauers. The cyd-1 (cyclin D) and cdk-4 genes function in
larval development to promote exit from the G1 stage of
the cell cycle [36]. Animals with loss of function of either
gene fail to carry out postembryonic divisions. We see a
significant reduction in expression of cdk-4  (Table 4),
which would be predicted to cause cells that would nor-
mally divide in reproductive L3 to arrest in dauers. How-
ever, loss of cdk-4 would not be expected to lead to an
arrest of all growth in dauers. Some cells in C. elegans have
endoreduplication without cell division, producing large
hyperploid cells. DBL-1 is a ligand in a TGFβ pathway that
controls larval growth [4,37]. dbl-1 mutants grow less than
wild type, and have lesser DNA content in hyperploid
hypodermal cells [38]. We see downregulation of dbl-1 in
dauers (Table 4), which may block endoreduplication,
and thereby arrest growth, in cell types such as intestine
and hypodermis. Thus the microarray analysis suggests aBMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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Table 4: Regulatory genes regulated by TGFβ signaling.
Hedgehog and Patched
Gene Type of gene Fold regulation p value Mountain
grd-2 groundhog -2.4 0.0005 14
grd-7 ground domain only 3.8 0.0003 13
grd-6 ground domain only -3.1 0.0002 16
grd-14 ground domain only -8.9 0.0002 16
wrt-7 warthog 6.7 0.01 17
wrt-1 warthog -6.8 0.0001 14
wrt-4 warthog -2.9 0.0003 14
wrt-6 warthog -2.7 0.0005 14
wrt-8 warthog -3.8 0.0005 14
wrt-2 wart domain only -1.8 0.008 14
C56A3.1 ground-like 4.8 0.0001 17
K03B8.7 ground-like 18.9 0.0003 17
ZC487.4 ground-like 3.4 0.009 17
C24G6.7 ground-like -3.6 0.0006 14
F42C5.7 ground-like -2.4 0.0007 1
T02E9.2 ground-like -7.7 0.0001 14
Y75B8A.20 ground-like -13.3 0.0001 14
ZC168.5 ground-like -4.6 0.0001 16
ptc-3 patched -2.1 0.0001 1
ptr-6 patched related -2.3 0.0008 14
ptr-11 patched related -2.6 0.0002 1
ptr-16 patched related -2.7 0.01 14
ptr-18 patched related -3.3 0.0002 16
ptr-23 patched related -2.5 0.0003 6
npc-2 patched family -2.5 0.0004 16
Dauer growth arrest
Gene Type of gene Fold regulation p value
dbl-1 TGFβ ligand, regulates growth and body size -2.4 0.001
cdk-4 cyclin dependent kinase -1.9 0.006
nhr-73 member of a family of NHR genes expressed exclusively in 
lateral hypodermis (seam cells)
-4.4 0.00002
nhr-74 member of a family of NHR genes expressed exclusively in 
lateral hypodermis (seam cells)
-5.5 0.00005
nhr-25 similar to NHR in Drosophila ecdysone regulatory cascade, 
required for embryogenesis and molting
-2.4 0.001
G-protein-coupled receptors and olfaction
gene type of gene fold regulation p value
srh-75 chemoreceptor 2.6 0.007
srh-195 chemoreceptor 2.6 0.0009
srj-32 chemoreceptor 5.8 0.002
sru-21 chemoreceptor 6.3 0.0007
32 genes chemoreceptor 1.8 to 6.3 0.05 or less
15 genes GPCR, not chemoreceptor type 1.8 to 3.6 0.05 or less
C30F12.6 thyrotropin-releasing hormone receptor ortholog 1.8 0.002
npp-10 GPCR, nucleoporin -1.8 0.001
6 genes chemoreceptors -1.8 to -3.8 0.05 or less
gpa-10 G protein alpha subunit 2.0 0.003
Y71H2B.7 G protein alpha subunit -1.8 0.0001
F45B8.2 regulator of G-protein signaling domain 2.4 0.03
gcy-22 receptor guanylate cyclase 2.7 0.03
gcy-31 soluble guanylate cyclase 1.8 0.01
gcy-34 soluble guanylate cyclase 1.8 0.03
tax-2 cyclic nucleotide gated channel beta subunit 3.0 0.02
lim-6 homeobox protein, functions to allow chemosensory 
neurons to sense different molecules
2.0 0.003
Notch pathway
gene type of gene fold regulation p value
W02C12.1 notch family 3.9 0.0007BMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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model for the arrest of both cell division and
endoreduplication.
Notch
Notch pathways have not been previously implicated in
dauer formation, but we see strong evidence for altered
activity of these pathways in dauer entry. Two of nine
genes annotated as Notch receptors in C. elegans show
strong upregulation in our data, as does one ligand, apx-1.
We also see regulation of two genes that act downstream
of the receptors: a shaggy/GSK3 kinase and lag-1, a tran-
scription factor [20]. The regulation of these various
Notch pathway components suggests that Notch signaling
has an important unidentified function in dauer
formation.
lin-28 and lin-29
These two genes are part of a signal transduction cascade
that regulates timing of developmental events during lar-
val development [39]. During larval growth, abundance
of the cold shock domain containing LIN-28 protein is
post transcriptionally downregulated. This
downregulation allows the zinc-finger transcription factor
LIN-29 to accumulate and promote events appropriate to
the third larval stage. In our data, lin-28 is upregulated,
and lin-29 downregulated (as expected, since lin-28 nega-
tively regulates lin-29). This regulation is consistent with
some old observations of the role of these genes in dauer
formation [40]. lin-28  loss-of-function mutants enter
dauer, but have defects in dauer morphogenesis. These
defects are suppressed by lin-29 mutations. The regulation
we see is consistent with the prediction that downregula-
tion of lin-29 by lin-28 is required for normal dauer mor-
phogenesis [40].
Discussion
Feedback model for crosstalk between TGFβ pathway and 
other dauer regulatory genes
We find that mutations in TGFβ signaling genes affects the
expression of numerous genes that are known regulators
of dauer formation. For example, loss of TGFβ signaling
causes reduction of expression of daf-2, would be expected
to reduce signaling through the insulin/IGF pathway. In
addition, the TGFβ pathway mutants have increased
expression of daf-12 and reduced expression of daf-9, a
cytochrome p450 that is predicted to be involved in the
biosynthesis of a daf-12 antagonist. All of these changes in
gene expression would be predicted to promote dauer for-
mation, and suggest that one way that the wild-type TGFβ
pathway promotes reproductive growth is by feedback
regulation of other dauer pathway genes.
We propose that this regulation is part of a feedback
mechanism that operates at many levels to insure a
"clean" dauer/non-dauer decision. Under conditions that
induce dauer formation to different extents, different per-
centages of the population form dauers, but individual
animals either undergo morphologically complete dauer,
or have no dauer morphogenesis; therefore, a mechanism
must exist to convert ambiguous signals into a clear deci-
sion. If reduced TGFβ signaling causes a reduction in insu-
lin/IGF signaling and vice versa, then weak signals can be
strengthened to make a clear, organism-wide decision.
Negative regulation of daf-12 and upregulation of daf-9 by
TGFβ and insulin/IGF signaling would likewise amplify
signals. Interestingly, daf-2 and daf-12 both function as
"nodes" for signal transduction in dauer entry. Many
genes function in TGFβ and insulin/IGF pathways in
dauer formation, but all of them except daf-2 show genetic
redundancy [1,3,8,21-23,41]. Regulation of genes other
than daf-2 would produce a weaker effect on dauer forma-
tion. Similarly, daf-12 is the gene that TGFβ and insulin/
IGF signaling converge on, and regulation of daf-12 would
be expected to have a uniquely powerful effect on dauer
formation.
The feedback regulation to the insulin/IGF pathway
explains published observations that link the TGFβ path-
way to the insulin/IGF pathway. First, daf-16 mutants par-
tially suppress daf-7  and other mutants in the TGFβ
pathway [3]. We suggest that feedback from the TGFβ
pathway to the insulin/IGF pathway is essential for com-
plete dauer formation. In this model, loss of daf-16 func-
tion does not have a direct effect on TGFβ signaling,
rather, daf-16 mutants suppress the inactivation of insu-
lin/IGF signaling that occurs in the TGFβ mutants. Sec-
F47C12.1 notch family 7.4 0.0003
apx-1 ligand for GLP-1, notch receptor 1.8 0.02
R03D7.5 shaggy/GSK3 kinase 2.2 0.002
lag-1 ortholog of CBF1 and Suppressor of Hairless 1.6 0.0003
Transcriptional regulators
gene type of gene fold regulation p value
lin-28 cold-shock domain 1.8 0.0001
lin-29 zinc finger transcription factor -1.9 0.0002
A complete list of significantly regulated regulatory genes can be found in additional file 4: Table S4.
Table 4: Regulatory genes regulated by TGFβ signaling. (Continued)BMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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ond, DAF-16 is localized to the nucleus when insulin/IGF
signaling is weak, for example in daf-2 mutants of all ages.
DAF-16 is localized to the nucleus in daf-7 mutants that
are entering dauer, but not at other stages [20]. We suggest
that this localization is a consequence of feedback regula-
tion from the TGFβ pathway to the insulin/IGF pathway.
Third, insulin/IGF pathway mutant adults have a variety
of stress-resistance phenotypes, including slowed aging,
which are shared with dauers, but not with TGFβ pathway
mutant adults. We suggest that the stress resistance seen in
daf-7 dauers is mostly or entirely caused by feedback reg-
ulation of the insulin/IGF pathway, and that this feedback
occurs in daf-7 mutant dauers, but not at other stages.
Regulation of insulin-like ligands and novel genes with 
similarity to insulin/IGF receptors suggests functions for 
these genes in dauer formation
We find several insulin-related genes and genes with sim-
ilarity to insulin receptor that are regulated by TGFβ sign-
aling. Four insulin-like genes are downregulated; these are
members of a subfamily in C. elegans that encodes several
agonists of insulin/IGF signaling. Published data suggest
that three of the downregulated insulin-like ligands act as
DAF-2 (receptor kinase) agonists [7,25,26]. Thus, down-
regulation of these genes and perhaps the closely related
gene ins-5 would be predicted to promote dauer entry,
and may be part of the feedback mechanism proposed
above. Published data suggest that ins-18, which is upreg-
ulated in our data, acts as a DAF-2 antagonist; [24] upreg-
ulation of this gene would be predicted to promote dauer
entry, and this gene is another candidate for participating
in the feedback mechanism proposed above. Upregula-
tion of ins-33 and ins-35 suggests that these genes, like ins-
18, encode receptor antagonists.
The ins-7 and ins-18 genes, but not the other insulin-like
genes in Table 3, are regulated by insulin/IGF signaling in
adults. Conversely, several insulin-like genes that are not
regulated in dauer entry are regulated by insulin/IGF sign-
aling in adults [26,42]. The gene programs induced by in
dauers have similarities to those induced in long-lived
adults; for example, stress resistance genes are common to
both. However, many gene regulatory programs are
unique to dauer, for example growth arrest. The different
spectrum of insulin-like genes expressed in dauer entry
versus adults may explain at least part of the difference in
events regulated by insulin/IGF signaling. As with the
insulin-like genes, we see both upregulation and down-
regulation of insulin-receptor like molecules; this regula-
tion identifies these genes as good targets for studies to
determine if this gene family is involved in insulin/IGF
pathway signal transduction. These results suggest that
diversity in insulin-related ligands, and perhaps in recep-
tors, contributes the ability of insulin/IGF signaling to
produce dramatically different phenotypes in dauers and
adults
Many strongly regulated early dauer genes have DAF-16 
regulatory sites
We observed that genes with putative daf-16 binding sites
show a tendency to be upregulated in our data, with the
exception of a small number of genes with daf-16 sites
downstream of the transcription start. These results are
important in several ways. Most significantly, our data
identify genes that may be directly regulated by DAF-16 to
control dauer formation or to provide dauer-specific func-
tions such as protection from environmental insults. Sec-
ond, genetics predicts that DAF-16 might upregulate genes
that promote dauer entry or downregulate genes that pro-
mote reproductive growth. Our results suggest that DAF-
16 can do both, but upregulated genes are much more
prominent in our data set. Third, we see that the direction
of regulation is correlated with the position of the DAF-16
site.
Our results show interesting similarities and differences
with recent reports about DAF-16 target genes
[53,54,42,43]. A significant number of genes that are
upregulated in our data are also upregulated in these other
experiments, but some genes are differently regulated.
These papers all examined gene expression in adults, and
in insulin/IGF pathway mutants, whereas our experi-
ments have perturbed but not mutated insulin/IGF signal-
ing (see below), so we would expect that only a subset of
genes would be in common. The most dramatic difference
between our data and these published reports is that we
see evidence for upregulation of genes by DAF-16 sites
upstream of the transcription start, but not downregula-
tion, whereas the other reports see as many upregulated
genes as downregulated genes. These differences suggest
that the activity of DAF-16 is fundamentally different in
dauers and adults, presumably because of availability of
different cofactors.
Other regulatory genes
Cytochrome p450s
A very large number of cytochrome p450s show strong
regulation in our data. One putative hormone biosyn-
thetic cytochrome p450, daf-9, is described above, and
these others may also participate in hormone metabo-
lism. Other microarray experiments have identified cyto-
chrome p450s as regulated genes in dauer or under the
control of insulin/IGF signaling in C. elegans [25,42,52].
Because of the diversity of functions of cytochrome p450s,
and especially because of the prominent roles of cyto-
chrome p450 in stress resistance, sorting out the function
of these genes in defense and hormone biosynthesis will
require detailed functional analysis.BMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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Hedgehog/Patched
The function of these genes is uncertain, as most have not
been studied. Based on the expression pattern of several
Ground and Wart domain proteins, Aspock et al.[34] sug-
gested a function for these genes in hypodermis. A com-
parison of regulated Hog and Patched genes to groups
("mountains") of putatively coregulated genes in C. ele-
gans [44] shows that three mountains are highly enriched
for these genes. Mount 14 and Mount 16, are enriched for
downregulated genes, and Mount 17 is enriched for
upregulated genes (Table 4). These mountains are even
more highly enriched for hog/patched  genes that are
strongly regulated in our experiments. These three moun-
tains have less than 5% of the genes in C. elegans, but 48%
of hog/patched genes and 80% of hog/patched genes that are
strongly regulated in our data. All three mountains are
also enriched for cuticular collagens; thus, we suggest that
the hog and patched genes function in the production of
the cuticle by the hypodermis. The fact that we see sub-
stantial numbers of both upregulated and downregulated
genes supports this hypothesis. Dauers and non-dauers
each form a cuticle, but with dramatically different struc-
tures [1]; therefore, we would expect to see the same types
of genes in each program, just as we do when examining
expression of cuticle structural genes such as collagens
and cuticlins (Table 2 and data not shown).
Olfaction and other G-protein-coupled receptor signaling
We see regulation of many genes that are candidate olfac-
tory and gustatory signal transduction molecules. This
regulation may be involved in changes in response to
odor and taste cues in dauers. We see many more upregu-
lated genes in this class than downregulated genes. How-
ever, both dauer and non-dauer larvae are responsive to
chemical cues, and published results of GPCRs with
dauer-regulated changes in expression of reporters are not
noticeably biased toward upregulation [45,46]. Perhaps
anatomical changes can explain the bias toward upregula-
tion. The key sensillum for regulation of dauer formation
is the amphid. In dauers, the amphid pore is filled with an
unknown material. In addition, ASI and ASG, which are
members of the subset of amphid neurons with a known
role in dauer formation, have shortened nerve endings
that are more distant from the pore [1]. These changes
insulate the neurons from the environment, to an extent.
For example, lipophilic dyes such as DiI are taken up by
amphid neurons in all stages of C. elegans development,
except in dauers [45,46]. However, dauers respond readily
to chemical cues that regulate dauer formation, which are
thought to be sensed by amphid neurons. Perhaps genes
that are required for chemosensation are more strongly
induced in dauers in order to compensate for reduced sig-
nals due to the reduced exposure of the sensory endings.
Conclusions
In summary, perhaps the most striking conclusions from
study are that, in TGFβ pathway mutants, we see altered
expression of many genes that are known regulators of
dauer formation, and that regulation of DAF-16 target
genes depends on the location of the DAF-16 binding site.
We see that loss of TGFβ signaling causes changes in gene
expression that would be expected to reduce signaling
through the insulin pathway. In addition, in TGFβ
mutants, we see increased expression of daf-12  and
reduced expression of daf-9, a cytochrome p450 that is
predicted to be involved in the biosynthesis of a daf-12
antagonist. We also see changes in expression of several
insulin-related genes and putative non-kinase insulin
receptors. This result suggests that diversity in insulin-
related ligands, and perhaps in receptors, contributes the
ability of insulin signaling to produce dramatically differ-
ent phenotypes in dauers and adults. We see evidence that
DAF-16 binding sites upstream of the coding region can
promote upregulation, but not downregulation of gene
expression.
We identify many other regulatory genes that have altered
expression in TGFβ mutants. We see several genes likely to
function in Notch pathway signaling; this is the first
implication of Notch signaling in dauer formation. We
find that many divergent C. elegans homologs of hunch-
back  and patched  are regulated by TGFβ. Because these
genes are coregulated with genes that encode structural
components of the cuticle, we suggest that these genes reg-
ulate the production of the dramatically different cuticles
of dauer and reproductive L3. We see coordinate regula-
tion of genes that are predicted to arrest cell division and
endoreduplication, which together would be expected to
promote growth arrest. We identify many genes that are
candidate hormone biosynthetic enzymes that might help
transduce signals from the nervous system to other tis-
sues. Figure 4 is a graphic summary of the main conclu-
sions of this work, with new regulatory relationships
suggested by our data shown in red.
Methods
RNA Isolation, cDNA synthesis, and microarray 
hybridization
Wild type is C. elegans variety Bristol, Strain N2; Daf-c gen-
otypes are daf-7(e1372), daf-8(e1393), and daf-14(m77).
Temperature-sensitive strains were maintained at 15°.
Eggs were collected by hypochlorite treatment and incu-
bated overnight at 15°. L1 larvae were grown on plates at
25°. During C. elegans larval development, each molt is
accompanied by a brief period of lethargus when the ani-
mal stops pharyngeal pumping, and sheds its old cuticle.
Cessation of pumping was scored according to [47] and
used to judge the stage of worms for harvesting. For com-
paring daf-7 to N2, worms were harvested at early L3 stageBMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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for N2, when >95% of the worm had entered the L3 stage
and daf-7 at early dauer stage when > 85% of the worm
had passed the L2d to dauer molt. Synchronization of
development in C. elegans populations is imperfect. For
daf-8/N2 and daf-14/N2 experiments, a small sample
plate was started 2 hours ahead of the harvest plates. The
worms were harvested at late L2 stages for N2 when the
worm on sample plate showed maximal cessation of
pumping and the very first animals on the harvesting
plates entered lethargus. daf-8 and daf-14 animals were
harvested at late L2d stage when 50% worm on the sam-
ple plates stopped pumping and the very first animals on
the harvesting plates entered lethargus. These animals
were not perfectly synchronous, but our monitoring of
pumping suggests that the vast majority of worms fall
within a four-hour developmental window. Worms were
harvested quickly to avoid changes in mRNA levels caused
by the collection procedure; no more than 15 minutes
elapsed between the start of harvest and addition of Tri-
zol. Each experiment compared RNA samples from the
wild-type N2 to Daf-c genotype worms. For each Daf-c
genotype, we did three or four independent experiments.
RNA was prepared as described previously [48]. Labeled
cDNA probe for DNA microarray hybridization was made
from 5 µg of poly (A)+ as described [49]. The two cDNA
probes were simultaneously hybridized to a single DNA
microarray.
Imaging and data analysis
Arrays were scanned using Axon scanner as described pre-
viously [49], collecting measurements for Cy5 and Cy3
separately. The average level of regulation for each gene
for each genotype was calculated as the mean of the Cy5/
Cy3 ratios. Genes with significant regulation were identi-
fied by using the standard deviation from the ten experi-
ments presented in this paper ("local standard deviation")
and the standard deviation derived from a several hun-
dred microarray experiments of various types ("global
standard deviation"), as described [50]. In most cases,
genes were considered significantly regulated only if they
were significant in a Student's t test using both measure-
ments of standard deviation. However, for a few hundred
genes, global standard deviation was unavailable, and sig-
nificance was measured using the local standard devia-
tion. Our processed, annotated data are available in
additional file 1: Table S1. Raw data compliant with the
"Minimum information about a microarray experiment"
(MIAME) standard is available at: http://genome-
www5.stanford.edu/.
Analysis of duplicated and reannotated spots
All spots on the array were generated by PCR of genomic
DNA, as described [49]. Some PCR reactions were spotted
in two separate locations on the array. In this case, both
data points were used to calculate the average regulation.
The PCR primers were designed a few years ago, and in
some cases, EST data or other information has revealed
that predictions upon which the primers were based were
in error [51]. Three types of error account for the vast
majority: 1) PCR products that are no longer believed to
amplify sequence from a gene. These spots are excluded
from the analysis. 2) Cases in which two PCR products
that were thought to represent two different genes actually
represent different parts of a single gene. In these cases,
each spot was initially analyzed independently, but, when
we count the number of genes with a particular property,
Model for gene regulatory events under the control of TGFβ signaling Figure 4
Model for gene regulatory events under the control of TGFβ signaling. Transcriptional regulatory events suggested 
by expression data in this paper are indicated in red. The TGFβ pathway is shown in green; DAF-3 and DAF-5 form a transcrip-
tion factor complex that function in neurons to control dauer entry [9]. DAF-3 and DAF-5 are shown regulating DAF-9 and 
DAF-12 indirectly because these genes are likely to be regulated in non-neuronal tissues. Insulin genes are shown as directly 
regulated by DAF-3 and DAF-5, but it is equally likely that these genes are regulated by feedback from the insulin pathway or 
by DAF-12.
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the genes are not double counted. 3) Cases in which a sin-
gle PCR product is now believed to overlap two genes.
Data from these spots were excluded from the analysis.
Fortunately, this type of error was uncommon.
Cross hybridization
Many genes in C. elegans have enough mRNA sequence
similarity that our labeled cDNA probes might hybridize
to homologous genes, obscuring true patterns of gene reg-
ulation. We examined our data and published data to
evaluate how widespread this problem is. As a crude
measure, we compared pairs of homologous genes and
asked whether the genes ever show opposite regulation.
Our expectation is that, if cross-hybridization is strong,
the two genes will show similar regulation. That is, if one
member of a pair shows upregulation in dauers and the
other member shows down-regulation, then cross-hybrid-
ization is not at a high enough level to obscure true
regulation. Of course, the converse is not necessarily true:
if two homologous genes show similar regulation, that
does not imply that cross hybridization is occurring.
We examined 8 groups of genes using blast to identify the
most similar genes. In this way, each of the eight genes
was matched with a small group of similar genes (6 were
collagens, one was cuticlin, and one was superoxide dis-
mutase). In seven groups, the match was approximately
80% identity over 200–700 bp, and several groups had
short stretches (<100 bp) of 90% identical sequence. In
each group, significantly different regulation was seen in
the data collected for this paper. The last group had
matches of >90% over 500 bases or more, and this group
showed strong correlation in our experiments.
This analysis defines the limits of specificity. For genes
with identities of <80%, and genes with short stretches of
90% identity, cross hybridization is not strong enough to
obscure differences between genes. When similarity goes
above 90% for more than 100 bp, genes show strongly
correlated expression, and these results should be inter-
preted with caution. Our examination of the collagen,
cytochrome p450, glutathione S-transferase, heat shock,
and peroxidase, insulin ligand, and insulin receptor fami-
lies of C. elegans indicates that no more than 10% of genes
in families have similarity great enough to be an issue. Of
course, this number applies to genes in families, and the
bulk of C. elegans genes will have less similarity.
Validation of the DNA microarray results
We examined our data to see if it was consistent with pub-
lished data on dauer gene regulation obtained by
Northern blot and reporter gene constructs. The term
"dauer-regulated" has been used in many published stud-
ies to describe results from experiments that are only
superficially similar. It would be inappropriate and mis-
leading to compare our data to most published data on
"dauer-regulated" genes. For example, Wang, et al. [52]
identified dauer-regulated genes, but they were examining
wild-type animals over time (rather than comparing
mutants to wild type) and studying the process of exiting
dauer (these animals were several days older than the ani-
mals we were studying. If we were to use this data to vali-
date our data, we would be making the assumption that
the set of genes that are regulated during dauer entry are
similar to the set of genes that are regulated in dauer exit.
There is no data to support this assumption. Comparison
of our data set to the Wang et al. [52] would be appropri-
ate to identify interesting similarities and differences
between dauer entry and exit, but to use one data set to
validate the other would be an error.
Most experiments that we consider inappropriate for use
in validation have one or both of the following
characteristics:
1) In our experiments and published experiments sum-
marized in Table 2, animals from which RNA is collected
are of similar age, either dauers near the L2d/dauer molt
or non-dauers near the L2/L3 molt. Many experiments
compare dauer RNA to that of mixed stage worms or adult
worms [53-55]. which is not useful for our goal of com-
paring the L3 to the dauer alternative. For example, using
mixed stage RNA, a gene that is expressed at a high level
in adults but is otherwise off, would be expected to show
expression in a mixed-stage RNA prep, but not in dauer
RNA. Yet a gene of this sort does not have a meaningful
relationship to the dauer/non-dauer decision or dauer
morphogenesis. Similarly, a gene that is expressed equally
in dauers and in non-dauer L3 animals would be diluted
by RNA from other stages, and therefore, less abundant, in
the mixed stage RNA than in the dauer RNA, but the gene
is not in fact more abundant in dauers than the non-dauer
alternative.
2) Many studies use dauers ranging from about 15 hours
to 7 days past the L2d/dauer molt [52,54-59]. Some of
these studies also compare starvation-induced dauers to
well-fed animals. These studies are often aimed toward
understanding issues related to survival of dauers and
aging. We would not expect that these studies would nec-
essarily find the same genes to be regulated, because of
differences in timing and differences in physiology due to
starvation. In particular, we are looking at the very begin-
ning of dauer morphogenesis, so would expect to see
genes that are necessary for dauer formation, while the
other studies are looking after the completion of dauer
morphogenesis, so would expect to see genes necessary for
dauer maintenance and survival.BMC Developmental Biology 2004, 4:11 http://www.biomedcentral.com/1471-213X/4/11
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We identified the small subset of experiments that are
appropriate for validation of our data set, by identifying
experiments that: compare animals close to the L2/L3 and
L2d/dauer molts. Table 2 shows that our data agrees very
well with published experiments of similar design. The
first five genes show strong regulation in the published
experiments, and 7–8-fold regulation in our experiments.
The next two genes, rnr-1, and col-2, are also regulated
similarly in our experiment and published data, although
the magnitude and statistical significance are not as great
as for the first 5 genes. The final gene, col-40, shows strong
upregulation at the L2d-dauer molt in published experi-
ments, but in our data does not show regulation. One pos-
sible explanation for this discrepancy is that this gene has
been shown to have very rapid induction and repression
near the time of molting [60,61]. Thus, seeing regulation
of  col-40  may depend on precisely when the RNA is
collected. This gene showed very high variation in
mutant/wildtype ratio from experiment to experiment,
higher than 99% of the genes on the array. This unusual
variation is consistent with the idea that timing is critical
for measuring regulation of this gene. A second possible
explanation is that the regulation of these genes is
obscured by cross-hybridization to other collagen genes;
however, the similarity of col-2 and col-40 to other genes
at the level of coding DNA is low enough that we do not
expect cross-hybridization to be a serious problem (see
previous section of Methods). Overall, seven of eight
genes show strong correlation with published data.
Identification of DAF-3 and DAF-16 binding sites
Binding sites for transcription factors were identified
using RSA tools [62,63].
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Additional File 1
Full data set. Table S1 may be found online as an Excel file at: http://lifesci/~patter 
sonlab/publication/MBCDBpaper/supplementary.htm Please feel free to use any 
annotation in these tables, provided that the original source of the data is cited, and 
this collection of annotations is cited. Table S1 has the data for all of the genes on the 
microarray. Raw data in unprocessed, MIAME compliant format is available at: http:/
/genome-www5.stanford.edu/. Column A, "SMD gene name" is the name given to 
the probe on the microarray. The probe is a PCR product from a pair of primers made 
to amplify the ORF named in this column (Reinke, V., Smith, H. E., Nance, J., 
Wang, J., Van Doren, C., Begley, R., Jones, S. J. M., Davis, E., Scherer, S., Ward, 
S., & Kim, S. K. (2000). Mol. Cell 6, 605–616). Many of these ORF predictions 
have changed, and the current match is in column B. Column B, "wormbase gene 
name" gives the current gene prediction that is complementary to the probe on the 
array. Columns C-K are annotations downloaded from Wormbase in 2003, from 
April to June. The column headings are defined in Wormbase. Columns L and M are 
optimal DAF-16 binding sites, which are the sequence TTGTTTAC. Negative num-
bers are sites upstream of the start of translation, and positive numbers are down-
stream of the stop codon. These sites were predicted in Fall 2002 using data and 
software from http://rsat.ulb.ac.be/rsat/ (van Helden, J., André, B., & Collado-Vides, 
J. (2000). Yeast 16,177–187.). All sites within 2000 bp upstream and 300 bp down-
stream are shown, except for a few (<2%) that we were not able to match because of 
different annotation in our database and the rsat database. Columns N-O are our 
annotation of function based on sequence similarity, annotation from wormbase, and 
published reports. For the following groups, we have annotated all genes in the group, 
to the best of our knowledge: G protein coupled receptors, glutathione S transferases, 
cytochrome p450s, heat shock proteins, peroxidases, UGTs, epoxide hydrolases, colla-
gens, cuticlins, NRF6 related, scl-1 familly (aka CRISP family), signaling proteins, 
and transcription factors. For the following groups, we have annotated only a subset of 
genes in the group: amine oxidases, ribosomal proteins, amino acid catabolism, and 
lipid metabolism. Column P, "mountains", lists groups of putatively co-regulated genes 
from Kim, S. K., Lund, J., Kiraly, M., Duke, K., Jiang, M., Stuart, J. M., Eizinger, 
A., Wylie, B. N., & Davidson, G. S. (2001). Science 293, 2087–2092. Column Q 
and R list the average ratio of signal from daf-c genotypes to wild-type, using all exper-
iments. Column Q is the average expressed as a base 2 logarithm (>0 means the 
expression was higher in daf-c, <0 is higher in N2, and Column R is the average 
expressed as a fold change (for both columns, a positive number means the expression 
was higher in daf-c, a negative number means the expression was higher in N2). Col-
umn S is the p value for the values in column Q and R, using a t test, asking the ques-
tion, given the standard deviation for the data, is the value significantly different from 
a ratio of 1 (or 0 for the base 2 log). For these calculations we used the local standard 
deviation and the global standard deviation as described in Jiang, M., Ryu, J., Kiraly, 
M., Duke, K., Reinke, V., & Kim, S. K. (2001). Proc. Natl. Acad. Sci. 98, 218–223. 
Column T is the number of successful experiments for each spot on the array. The 
numbers vary because the data for a particular spot may or may not be of acceptable 
quality for a given experiment. Some genes have a number greater than 10 (the total 
number of independent experiments) because the same PCR product was put on the 
array in two different locations. Columns U thru BH are the data for each spot for 
each experiment. The column labeled "CH1D_MEAN" is the data for wild-type sam-
ple, the column labeled CH2D_MEAN is the data for the daf-c mutant sample, the 
column labeled CORR is the correlation coefficient for the average ratio of channel 1 
to channel 2 calculated pixel by pixel, and the column labeled Flag indicates the data 
quality. Any value other than 0 indicates that the data had problems and was not used 
for analysis. Columns BL to CG give the data broken down by genotype (for each of 
the three daf-c genotypes used in this study). For each genotype, the first three or four 
columns give the base 2 log of the ratio of channel 2 (from daf-c genotype) to channel 
1 (from wild type) for each experiment. Blank cells indicate bad data, not used in the 
analysis. The five digit number in the headings of these colums refer to the experiment 
ID used to catalog data at the Stanford Microarray Database. The next column gives 
the average ratio, the next column the standard deviation and the next gives the 
number of successful experiments, and the next the p value, asking the question, given 
the standard deviation for the data, is the value significantly different from a ratio of 
1 (or 0 for the base 2 log).
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